Executive Director, Cell Therapy Global Supply Chain Planning

If you have the passion and the drive to accelerate growth and make people’s lives better – then AstraZeneca is the place for you.  We have a big ambition – to deliver more medicines to patients, quicker and more affordably. Backed by the investment, leadership and a clear plan to get there, we bring personal dedication and out of the box thinking. 

AstraZeneca turns molecules to medicines, bringing our Research & Development pipeline to life through a rigorous process of development, manufacturing, testing and delivery.  Operations is accelerating fast. We are on track for Our Bold Ambition 2030, delivering 15+ new medicines driving us forward across different modalities including biologics, cell therapy, ADCs and small molecules. 

The Opportunity

AstraZeneca is building one of the industry’s most ambitious Cell Therapy portfolios, spanning autologous, allogeneic, and in vivo modalities. As the business evolves from clinical-stage operations to global commercial scale, we are seeking a senior leader to build the planning capability that will support reliable patient supply, successful launches, and long-term growth.

The Executive Director, Cell Therapy Global Supply Chain Planning reports into the Vice President, Cell Therapy Global Supply Chain and will lead the transformation of planning for the Cell Therapy business. You will shape the operating model, build the organization and capabilities, and establish the governance, processes, and systems needed to support a complex, global, multi-product portfolio.

This is a highly visible leadership role with broad enterprise impact owning the decision architecture that aligns assumptions, risks, priorities, and tradeoffs across the enterprise to enable effective executive decision making. You will work across Commercial, Clinical, Finance, Manufacturing, Quality, Process Development, Regulatory, CMC, and Supply Chain to create a modern, integrated planning function aligned to AstraZeneca’s long-term Cell Therapy ambition.

Responsibilities

• Lead the end-to-end planning function for Cell Therapy, connecting commercial demand, clinical enrollment, patient flow, supply planning, inventory strategy, materials planning, capacity planning, and financial assumptions into a unified planning framework that is appropriate to patient-specific therapies

• Lead the transformation of the planning operating model from a clinical-stage environment to a scalable global commercial capability, including organization design, governance, decision rights, processes, and ways of working

• Build the planning capabilities needed to support growth, including launch readiness, market expansion, increasing product and geographic complexity, and volume growth across the portfolio

• Lead S&OP/IBP and S&OE as enterprise decision-making forums, establishing the planning and governance architecture that aligns cross-functional assumptions, risks, priorities, and scenarios, and enables timely executive decisions across service, cost, cash, risk, and growth

• Drive cross-functional executive alignment across Commercial, Clinical, Finance, Manufacturing, Quality, Process Development, Regulatory, CMC, and Supply Chain, ensuring assumptions, constraints, priorities, and trade-offs are transparent, reconciled, and translated into clear enterprise decisions

• Develop differentiated planning strategies across autologous, allogeneic, and in vivo modalities, as well as across clinical and commercial supply models, product lifecycle stages, and markets

• Lead global network and capacity planning across internal manufacturing sites and external partners, including capacity allocation, slot management, and supply prioritization across products, programs, and geographies, and partner with the Network Strategy team to align long-range planning, network expansion, and future-state supply network decisions with business growth and portfolio needs

• Provide integrated decision making and planning of Supply Chain within CMC program governance, ensuring supply, logistics, and capacity constraints are translated into clear direction and integrated supply plans

• Oversee the planning architecture across Plan-to-Deliver, from demand translation through supply planning, detailed scheduling, and execution handoffs to drive planning excellence through patient outcomes such as vein-to-vein time and slot availability

• Lead scenario planning and planning risk management, helping the business anticipate and respond to supply, capacity, logistics, and launch risks

• Drive future state digital plann